Page last updated: 2024-12-06

n-acetylbenzidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID18787
SCHEMBL ID3225408
MeSH IDM0107365

Synonyms (41)

Synonym
(1,1'-biphenyl)-4,4'-diamine, n-acetyl-
acetamide, n-(4'-amino(1,1'-biphenyl)-4-yl)-
brn 2806506
ccris 5166
LS-11528
4'-acetamidobenzidine
4'-(p-aminophenyl)acetanilide
nsc 508901
3366-61-8
monoacetylbenzidine
acetanilide, 4'-(p-aminophenyl)-
nsc508901
n-acetylbenzidine
4-acetylamino-4'-aminobiphenyl
benzidine, n-acetyl-
nsc-508901
wln: zr dr dmv1
[1,4'-diamine, n-acetyl-
n-acetylbenzidin
4-acetamido-4'-aminobiphenyl
OPREA1_125494
n-[4-(4-aminophenyl)phenyl]acetamide
AKOS002813326
n-acetylbenzidin [czech]
unii-q1i4im38kc
q1i4im38kc ,
3-13-00-00437 (beilstein handbook reference)
acetanilide, p-(p-aminophenyl)-
acetylbenzidine
acetamide, n-(4'-amino[1,1'-biphenyl]-4-yl)-
SCHEMBL3225408
DTXSID4036853
J-523432
n-(4'-aminobiphenyl-4-yl)acetamide
mfcd00047857
Q26840965
n-(4'-amino-biphenyl-4-yl)-acetamide
n-(4'-amino-[1,1'-biphenyl]-4-yl)acetamide
SB79759
n-{4'-amino-[1,1'-biphenyl]-4-yl}acetamide
CS-0320333

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Arylamine-hemoglobin conjugates identified as sulfinamides are considered dosimeters for the bioavailability of metabolically formed N-oxidation products."( Sulfinamide formation following peroxidatic metabolism of N-acetylbenzidine.
Davis, BB; Hsu, FF; Lakshmi, VM; Zenser, TV, 2000
)
0.55

Dosage Studied

ExcerptRelevanceReference
" Dose-response inhibition studies with estriol and 4-aminobiphenyl demonstrated that each agent reached a plateau as its concentration was increased."( Glucuronidation of N-acetylbenzidine by human liver.
Babu, SR; Davis, BB; Lakshmi, VM; Zenser, TV,
)
0.46
" The nonspecific cytochrome P450 inhibitor SKF-525A (10 microM) exhibited a partial dose-response inhibition (maximum 41% of complete reaction mixture) of N'HA formation, but did not alter NHA formation."( Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Davis, BB; Lakshmi, VM; Zenser, TV, 1997
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (28.00)18.7374
1990's10 (40.00)18.2507
2000's8 (32.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.07 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]